CoreAge Rx vs Aspen
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Aspen head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Aspen a bad call — it's best for readers who can confirm the full selected-plan charge and distinguish recurring care from prepaid financing. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Aspen |
|---|---|---|
| Brief Score | 94/100 (A) | 75/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm a medication-specific quote Generic GLP-1 offer from $179/mo requires a three-month commitment; full semaglutide charge and supplied quantity unconfirmed. Full price detailsCompounded semaglutide offered; current molecule-specific complete quote unknown; generic GLP-1 starting figure $179 with three-month commitment; earlier listing: From $279/mo (3-month plan, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm a medication-specific quote Current full tirzepatide charge and supplied quantity unconfirmed. Do not apply the generic $179 GLP-1 offer to both medications. Full price detailsCompounded tirzepatide offered; current molecule-specific complete quote unknown; earlier listing: From $399/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises all 50 states plus DC; dispensing location and prescription eligibility can limit access |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Aspen: Generic $179 GLP-1 figure carries three-month commitment; complete molecule-specific quotes remain unconfirmed. Recurring and financed plans have different rules.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.